[
  {
    "ts": "2026-02-16T15:52:00+00:00",
    "headline": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
    "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
    "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c4468f67-119b-3826-873e-3263fa39efa1",
      "content": {
        "id": "c4468f67-119b-3826-873e-3263fa39efa1",
        "contentType": "STORY",
        "title": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
        "description": "",
        "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
        "pubDate": "2026-02-16T15:52:00Z",
        "displayTime": "2026-02-16T15:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-16T16:32:00+00:00",
    "headline": "CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT",
    "summary": "CDNA shares climb after AlloHeme data show early AML/MDS relapse detection, backing its Transplant+ expansion into cell therapy markets.",
    "url": "https://finance.yahoo.com/news/caredx-reports-positive-data-alloheme-163200402.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "7ed9faa1-13e3-305a-9336-f2e055e3170e",
      "content": {
        "id": "7ed9faa1-13e3-305a-9336-f2e055e3170e",
        "contentType": "STORY",
        "title": "CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT",
        "description": "",
        "summary": "CDNA shares climb after AlloHeme data show early AML/MDS relapse detection, backing its Transplant+ expansion into cell therapy markets.",
        "pubDate": "2026-02-16T16:32:00Z",
        "displayTime": "2026-02-16T16:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890",
          "originalWidth": 620,
          "originalHeight": 393,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/owRrQw..RZz13mqQwVBgRA--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890.cf.webp",
              "width": 620,
              "height": 393,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xvPk7PEgDBlSHxNlV1Nayw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/caredx-reports-positive-data-alloheme-163200402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/caredx-reports-positive-data-alloheme-163200402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": null,
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]